Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma

The inhibition of apoptosis in cancer cells is the major pathological feature of hepatic carcinoma. Rosiglitazone (RGZ), a ligand for peroxisome proliferator-activated receptor γ (PPAR-γ), has been shown to induce apoptosis in hepatic carcinoma cells. However, the mechanism underlying this effect re...

Descripción completa

Detalles Bibliográficos
Autores principales: BO, QI-FU, SUN, XIU-MEI, LIU, JIN, SUI, XIAO-MEI, LI, GUI-XIN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579902/
https://www.ncbi.nlm.nih.gov/pubmed/26622783
http://dx.doi.org/10.3892/ol.2015.3554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579902/
https://www.ncbi.nlm.nih.gov/pubmed/26622783
http://dx.doi.org/10.3892/ol.2015.3554

Ejemplares similares